We invite you to read the new scientific article "Pharmacokinetics and bioequivalence study of two-component drug "Ezetimibe + rosuvastatin" (Sanofi-Aventis Group, Russia): results and experience of enzymatic hydrolysis in the analysis of samples" co-authored by Dmitry Grebenkin and Vasily Kazey, employees of the Analytical Center of Exacte Labs.
The article was published in the scientific and manufacturing peer-reviewed journal Drug development & registration.
The article describes an example of bioequivalence study of a drug using hydrolysis of its metabolite. The author's additional parameters of enzymatic hydrolysis control for bioanalytical methods have demonstrated their effectiveness.
The full text of the publication can be found here.